DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
OSI-027
1
Small molecule
Investigational
Unknown
Unknown
Lymphedema; Lymphoma
Serine/threonine-protein kinase mTOR inhibitor
OSI-027
×
Maximum Phase:
1
First Approval:
None
UNII:
25MKH1SZ0M
Molecule Type:
Small molecule
Molecular Formula:
C21H22N6O3
Molecular Weight:
406.45
AlogP:
3.22
PSA:
131.42
HBD:
3.0
HBA:
#RotB:
4.0
Source:
SAFINGOL
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SAFINGOL
×
Maximum Phase:
1
First Approval:
None
UNII:
OWA98U788S
Molecule Type:
Small molecule
Molecular Formula:
C18H39NO2
Molecular Weight:
301.52
AlogP:
4.15
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
16.0
Source:
CEP-37440
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
ALK tyrosine kinase receptor inhibitor
CEP-37440
×
Maximum Phase:
1
First Approval:
None
UNII:
O3MNS8782H
Molecule Type:
Small molecule
Molecular Formula:
C30H38ClN7O3
Molecular Weight:
580.13
AlogP:
3.84
PSA:
114.88
HBD:
4.0
HBA:
#RotB:
9.0
Source:
MOFAROTENE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Retinoid receptor modulator
MOFAROTENE
×
Maximum Phase:
1
First Approval:
None
UNII:
8K3CVY8F8V
Molecule Type:
Small molecule
Molecular Formula:
C29H39NO2
Molecular Weight:
433.64
AlogP:
6.31
PSA:
21.7
HBD:
0.0
HBA:
#RotB:
6.0
Source:
2-DEOXY-D-GLUCOSE
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant; Common Cold
Unknown
2-DEOXY-D-GLUCOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
9G2MP84A8W
Molecule Type:
Small molecule
Molecular Formula:
C6H12O5
Molecular Weight:
164.16
AlogP:
-2.19
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
1.0
Source:
SC-43
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SC-43
×
Maximum Phase:
1
First Approval:
None
UNII:
OT4AQX5MLU
Molecule Type:
Small molecule
Molecular Formula:
C21H13ClF3N3O2
Molecular Weight:
431.8
AlogP:
6.67
PSA:
74.15
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ISOAMYL 2-CYANOACRYLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ISOAMYL 2-CYANOACRYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MSC-2363318A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MSC-2363318A
×
Maximum Phase:
1
First Approval:
None
UNII:
0DXG50I4WD
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RGX-104
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RGX-104
×
Maximum Phase:
1
First Approval:
None
UNII:
Q26B92650V
Molecule Type:
Small molecule
Molecular Formula:
C34H33ClF3NO3
Molecular Weight:
596.09
AlogP:
8.48
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
13.0
Source:
ABTL-0812
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ABTL-0812
×
Maximum Phase:
1
First Approval:
None
UNII:
0DE74TJ7EZ
Molecule Type:
Small molecule
Molecular Formula:
C18H32O3
Molecular Weight:
296.45
AlogP:
4.86
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
14.0
Source:
PIVAGABINE
1
Small molecule
Investigational
Unknown
Unknown
Anxiety; Depressive Disorder
Unknown
PIVAGABINE
×
Maximum Phase:
1
First Approval:
None
UNII:
C53SV0WO4V
Molecule Type:
Small molecule
Molecular Formula:
C9H17NO3
Molecular Weight:
187.24
AlogP:
1.01
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
4.0
Source:
OLOCROLIMUS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
FK506-binding protein 1A inhibitor
OLOCROLIMUS
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-3009120
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Neoplasm Metastasis
Serine/threonine-protein kinase A-Raf inhibitor
LY-3009120
×
Maximum Phase:
1
First Approval:
None
UNII:
1GDT36RARO
Molecule Type:
Small molecule
Molecular Formula:
C23H29FN6O
Molecular Weight:
424.52
AlogP:
5.05
PSA:
91.83
HBD:
3.0
HBA:
#RotB:
5.0
Source:
S-3304
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasms
Unknown
S-3304
×
Maximum Phase:
1
First Approval:
None
UNII:
BK459F050X
Molecule Type:
Small molecule
Molecular Formula:
C24H20N2O4S2
Molecular Weight:
464.57
AlogP:
3.91
PSA:
99.26
HBD:
3.0
HBA:
#RotB:
6.0
Source:
NP031112
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NP031112
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATB-346
1
Small molecule
Investigational
Unknown
Unknown
Chronic Pain; Stomach Ulcer; Osteoarthritis
Unknown
ATB-346
×
Maximum Phase:
1
First Approval:
None
UNII:
3096O7WP53
Molecule Type:
Small molecule
Molecular Formula:
C21H19NO3S
Molecular Weight:
365.45
AlogP:
4.19
PSA:
61.55
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LGX-806
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase B-raf inhibitor
LGX-806
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLPG0259
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GLPG0259
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KPT-9274
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
KPT-9274
×
Maximum Phase:
1
First Approval:
None
UNII:
9T56TV18X7
Molecule Type:
Small molecule
Molecular Formula:
C35H29F3N4O3
Molecular Weight:
610.64
AlogP:
7.08
PSA:
101.46
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ABT 737
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
ABT 737
×
Maximum Phase:
1
First Approval:
None
UNII:
Z5NFR173NV
Molecule Type:
Small molecule
Molecular Formula:
C42H45ClN6O5S2
Molecular Weight:
813.45
AlogP:
7.88
PSA:
128.13
HBD:
2.0
HBA:
#RotB:
16.0
Source:
ZIDEBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
ZIDEBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
YPM97423DB
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O7S
Molecular Weight:
391.41
AlogP:
-1.86
PSA:
157.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
CG200745
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CG200745
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INZOMELID
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Unknown
INZOMELID
×
Maximum Phase:
1
First Approval:
None
UNII:
SC4RYG0M76
Molecule Type:
Small molecule
Molecular Formula:
C19H24N4O3S
Molecular Weight:
388.49
AlogP:
2.95
PSA:
93.09
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BMS-698769
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
BMS-698769
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIP-1095 I-123
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIP-1095 I-123
×
Maximum Phase:
1
First Approval:
None
UNII:
HD4940602J
Molecule Type:
Small molecule
Molecular Formula:
C19H25IN4O8
Molecular Weight:
560.33
AlogP:
1.65
PSA:
194.16
HBD:
7.0
HBA:
#RotB:
13.0
Source:
TEGLARINAD
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TEGLARINAD
×
Maximum Phase:
1
First Approval:
None
UNII:
NUG9P5GWZB
Molecule Type:
Small molecule
Molecular Formula:
C30H43ClN5O8+
Molecular Weight:
637.15
AlogP:
3.91
PSA:
145.77
HBD:
2.0
HBA:
#RotB:
23.0
Source:
GSK-2018682
1
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
Unknown
GSK-2018682
×
Maximum Phase:
1
First Approval:
None
UNII:
NJL503AIJA
Molecule Type:
Small molecule
Molecular Formula:
C22H21ClN4O4
Molecular Weight:
440.89
AlogP:
5.06
PSA:
103.27
HBD:
1.0
HBA:
#RotB:
8.0
Source:
E-7820
1
Small molecule
Investigational
Unknown
Unknown
Colonic Neoplasms; Colorectal Neoplasms; Neoplasms; Rectal Neoplasms
Unknown
E-7820
×
Maximum Phase:
1
First Approval:
None
UNII:
TVH5K7949N
Molecule Type:
Small molecule
Molecular Formula:
C17H12N4O2S
Molecular Weight:
336.38
AlogP:
3.02
PSA:
109.54
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MK-0752
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Neoplasms
Unknown
MK-0752
×
Maximum Phase:
1
First Approval:
None
UNII:
9JD9B4S53T
Molecule Type:
Small molecule
Molecular Formula:
C21H21ClF2O4S
Molecular Weight:
442.91
AlogP:
5.34
PSA:
71.44
HBD:
1.0
HBA:
#RotB:
6.0
Source:
RO-3201195
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
RO-3201195
×
Maximum Phase:
1
First Approval:
None
UNII:
TE3ESF890C
Molecule Type:
Small molecule
Molecular Formula:
C19H18FN3O4
Molecular Weight:
371.37
AlogP:
1.56
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
7.0
Source:
GMI-1271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GMI-1271
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CPI-1205
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Follicular; Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CPI-1205
×
Maximum Phase:
1
First Approval:
None
UNII:
455J2479FY
Molecule Type:
Small molecule
Molecular Formula:
C27H33F3N4O3
Molecular Weight:
518.58
AlogP:
4.72
PSA:
79.36
HBD:
2.0
HBA:
#RotB:
7.0
Source:
HSD-016
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HSD-016
×
Maximum Phase:
1
First Approval:
None
UNII:
C4I13768E1
Molecule Type:
Small molecule
Molecular Formula:
C21H21F7N2O3S
Molecular Weight:
514.46
AlogP:
4.51
PSA:
60.85
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ORE-1001
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
ORE-1001
×
Maximum Phase:
1
First Approval:
None
UNII:
4LD0ZHV25K
Molecule Type:
Small molecule
Molecular Formula:
C19H23Cl2N3O4
Molecular Weight:
428.32
AlogP:
3.32
PSA:
104.45
HBD:
3.0
HBA:
#RotB:
10.0
Source:
PA-799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PA-799
×
Maximum Phase:
1
First Approval:
None
UNII:
JCL936W835
Molecule Type:
Small molecule
Molecular Formula:
C15H19N7O3S
Molecular Weight:
377.43
AlogP:
-0.33
PSA:
127.43
HBD:
1.0
HBA:
#RotB:
3.0
Source:
1
2
…
67
68
69
70
71
72
73
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA